Following Eli Lilly and Johnson & Johnson, Sanofi is aiming to change how it participates in the 340B program, a federal drug pricing program created in 1992, The Wall Street Journal reported Nov. 22.
On October 30, HRSA announced that it had selected eight drug manufacturers to participate in its 340B Rebate Model Pilot Program, spanning 10 drugs representing a range of widely used therapies.
MedPage Today on MSN
Hospitals, drugmakers, and US government continue battle over 340B program
The drug discount program is under scrutiny on a variety of fronts ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results